Key Highlights

• KLA Corporation Leads in Short Interest: Short interest above 36% of float has amplified KLA's upside moves following positive catalysts.

• Pagaya and 4D Molecular Also Elevated: Short interest near 19% for Pagaya and 24% for 4D Molecular Therapeutics adds squeeze potential.

• Pattern of Amplified Reactions: Positive surprises in heavily shorted names produce outsized price reactions as short covering compounds buying interest.

Elevated short interest is fueling speculative dynamics across several 2026 movers, creating conditions where positive catalysts can trigger outsized price reactions beyond what fundamental analysis alone would suggest.

KLA Corporation (NASDAQ: KLAC) carries short interest above 36% of float, an exceptionally elevated level that has amplified the stock's upside moves following positive catalysts including analyst price target hikes and strong advanced packaging revenue guidance.

Pagaya Technologies (NASDAQ: PGY) sits near 19% short interest, with the figure cited by B. Riley analyst Harold Goetsch as a factor that could face pressure as the company's fundamentals continue to improve following recent positive earnings and insider buying activity.

4D Molecular Therapeutics (NASDAQ: FDMT) is near 24% short interest, with the combination of early Phase 3 enrollment completion and a new credit facility creating the conditions for short covering that pushed shares to a 52-week intraday high on nearly double average volume.

The pattern across these three very different companies — semiconductor equipment, fintech lending, and clinical-stage biotech — suggests that positive surprises in heavily shorted names can produce outsized price reactions as short covering compounds genuine buying interest, regardless of sector.

()